Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma in the Setting of Cirrhosis
Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma in the Setting of Cirrhosis
复制标题
肝硬化背景下肝切除与肝移植对小肝内胆管癌和混合性肝细胞胆管癌的疗效分析
DOI：
10.1002/lt.25737
复制
发表时间：
2020-06-01
影响因子：
4.6
通讯作者：
Vibert, Eric
中科院分区：
文献类型：
--
作者：
De Martin, Eleonora;Rayar, Michael;Vibert, Eric
这项多中心研究比较了2002年1月至2015年7月期间接受肝移植（LT）或肝切除术（LR）的肝硬化患者的结局，这些患者患有在自体肝脏中偶然发现的肝内胆管细胞癌（iCCA）或肝细胞-胆管细胞癌联合（cHCC-CCA）。共49例（65%）肝硬化LT和26例（35%）LR患者，组织学证实iCCA/cHCC-CCA 2 cm，但
This multicenter study compares the outcomes of patients with cirrhosis undergoing liver transplantation (LT) or liver resection (LR) between January 2002 and July 2015 who had intrahepatic cholangiocarcinoma (iCCA) or combined hepatocellular-cholangiocarcinoma (cHCC-CCA) found incidentally in the native liver. A total of 49 (65%) LT and 26 (35%) LR patients with cirrhosis and histologically confirmed iCCA/cHCC-CCA 2 cm but